Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Dyslipidemia

Free Subscription 17.06.2024 1 Am Heart J 5 Atherosclerosis 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. NICHOLLS SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, et al
   Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in Participants With or at High Risk for Atherosclerotic Cardiovascular Disease: Rationale and Designs of BROADWAY and BROOKLYN.
   Am Heart J. 2024 May 3:S0002-8703(24)00116-9. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

2. HENDY LE, Spees LP, Tak C, Carpenter DM, et al
   An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients.
   Atherosclerosis. 2024;393:117541.
   PubMed         Abstract available
   
   
3. HARADA-SHIBA M
   How can we improve the prognosis of patients with homozygous familial hypercholesterolemia?
   Atherosclerosis. 2024 Apr 16:117551. doi: 10.1016/j.atherosclerosis.2024.117551.
   PubMed        
   
   
4. IBRAHIM S, Nurmohamed NS, Nierman MC, de Goeij JN, et al
   Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.
   Atherosclerosis. 2024;393:117548.
   PubMed         Abstract available
   
   
5. MASROURI S, Tamehri Zadeh SS, Shapiro MD, Khalili D, et al
   Impact of optimal cholesterol levels on subclinical atherosclerosis in the absence of risk factors in young adults.
   Atherosclerosis. 2024;393:117520.
   PubMed         Abstract available
   
   
6. ALONSO R, Arroyo-Olivares R, Diaz-Diaz JL, Fuentes-Jimenez F, et al
   Improved lipid-lowering treatment and reduction in cardiovascular disease burden in homozygous familial hypercholesterolemia: The SAFEHEART follow-up study.
   Atherosclerosis. 2024 Mar 16:117516. doi: 10.1016/j.atherosclerosis.2024.117516.
   PubMed         Abstract available
   
   

   
   PLoS One

7. MIRZAMOHAMADI S, HajiAbbasi MN, Roshandel G, Alimadadi M, et al
   Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran.
   PLoS One. 2024;19:e0300736.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.